New research indicates the best available chemotherapy for Kaposi Sarcoma, which is infrequently used in Africa, is cost effective and would improve clinical outcomes. Although antiretroviral therapy ...

Blockade of Platelet-Derived Growth Factor Receptor-Beta by CDP860, a Humanized, PEGylated di-Fab', Leads to Fluid Accumulation and Is Associated With Increased Tumor Vascularized Volume Activation of ...

Please provide your email address to receive an email when new articles are posted on . The incidence of Kaposi’s sarcoma and related death in East Africa has not improved in the last 5 years. In a ...

Kaposi's sarcoma (KS) is a disease of multifocal vascular proliferation that requires infection with KS herpes virus (KSHV/HHV-8). Activation of the c-kit and platelet-derived growth factor (PDGF) ...

Although antiretroviral therapy has markedly improved survival in people with AIDS-associated Kaposi sarcoma (a type of cancer caused by a virus), the condition is still a life-threatening problem in ...

This article is brought to you by LSU LCMC Health Cancer Center. LSU LCMC Health Cancer Center researchers continue to make progress in discovering connections between HIV and certain cancers, and are ...

A study has identified a binding protein in cancer cell's nucleus, known as CHD4, as a critical agent keeping Kaposi's sarcoma-associated herpesvirus (KSHV) dormant and undetected by the body's immune ...

Investigators also examined which type of immunosuppression was associated with a higher likelihood of Kaposi sarcoma. Findings presented at this month’s National Comprehensive Cancer Network (NCCN) ...